ABBOTT LABORATORIES — Director's Dealing 2014

Sep 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-09-18

Reporting Person: Fussell Stephen R (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-18	Common shares without par value	M	14500	$22.267	Acquired	124264	Direct
2014-09-18	Common shares without par value	M	17400	$23.2184	Acquired	141664	Direct
2014-09-18	Common shares without par value	F	23619	$43.38	Disposed	118045	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-18	Option (right to buy)	$22.267	M	14500	Disposed	2015-02-17	Common shares (14500)	Direct
2014-09-18	Option (right to buy)	$23.2184	M	17400	Disposed	2015-05-31	Common shares (17400)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1256	Indirect
Common shares without par value	53	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of September 18, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.